Shalini Singh | Clinical Pharmacology | Women Researcher Award

Published on 04/08/202604/08/2026 by Top Pharmaceutical

Women Researcher Award

Shalini Singh
Global Cosmetic Regulatory Services Pvt Ltd, India

Shalini Singh
Affiliation	Global Cosmetic Regulatory Services Pvt Ltd
Country	India
Google Scholar	N3KRvykAAAAJ
Documents	41
Citations	159
h-index	7
Subject Area	Clinical Pharmacology
Event	International Top Pharmaceutical Awards
ORCID	0000-0002-3743-8888

Shalini Singh is an Indian researcher associated with Global Cosmetic Regulatory Services Pvt Ltd, where her work focuses on clinical pharmacology, pharmaceutical regulation, cosmetic science, regulatory compliance, and healthcare quality. Her scholarly contributions demonstrate sustained engagement in pharmaceutical research, evidence-based regulatory practices, and scientific documentation. Through peer-reviewed publications and collaborative investigations, she has contributed to improving regulatory understanding and pharmaceutical safety within both academic and industrial environments.[1] Her research profile reflects interdisciplinary expertise spanning clinical pharmacology, pharmaceutical sciences, cosmetic regulation, and healthcare innovation.[2]

Contents

Abstract
Keywords
Introduction
Research Profile
Research Contributions
Publications
Research Impact
Award Suitability
Conclusion
External Links
References

Abstract

Shalini Singh has established a research portfolio centered on clinical pharmacology, cosmetic regulatory affairs, pharmaceutical quality systems, and healthcare compliance. Her scholarly work emphasizes the integration of scientific evidence with regulatory frameworks to support safe pharmaceutical development, effective cosmetic product evaluation, and quality assurance practices. Through published research and professional collaborations, she has contributed to advancing regulatory science while promoting responsible innovation across pharmaceutical and cosmetic industries. Her publication record, citation profile, and continued academic engagement indicate consistent participation in multidisciplinary pharmaceutical research.[1][3]

Keywords

Clinical Pharmacology, Regulatory Affairs, Cosmetic Regulations, Pharmaceutical Sciences, Drug Safety, Pharmacovigilance, Regulatory Compliance, Healthcare Quality, Pharmaceutical Quality Assurance, Cosmetic Science, Evidence-Based Medicine, Pharmaceutical Documentation, Clinical Research, Drug Development, Regulatory Science, Product Safety, Pharmaceutical Innovation, Healthcare Regulations, Scientific Publishing, Pharmaceutical Policy.

Introduction

Clinical pharmacology and pharmaceutical regulation play essential roles in ensuring the safety, efficacy, and quality of healthcare products throughout their life cycle. Researchers working in these fields contribute to scientific advancement by strengthening regulatory systems, supporting evidence-based decision-making, and improving public health outcomes. Regulatory professionals also facilitate the translation of scientific discoveries into compliant pharmaceutical and cosmetic products that meet international standards.[2]

Research Profile

The academic profile of Shalini Singh reflects sustained contributions to pharmaceutical sciences with emphasis on clinical pharmacology and regulatory science. Her scholarly metrics include forty-one indexed publications, one hundred fifty-nine citations, and an h-index of seven, indicating continued academic visibility and citation impact within her research community.[1]

Research Contributions

Shalini Singh has contributed to pharmaceutical and clinical research through publications focusing on regulatory science, cosmetic product compliance, pharmaceutical quality assurance, drug safety, and evidence-based healthcare practices. Her research supports the development of scientifically validated regulatory frameworks while encouraging harmonization between pharmaceutical innovation and international compliance standards.[2][3]

Publications

The publication portfolio of Shalini Singh demonstrates continuous scholarly activity within pharmaceutical sciences and clinical pharmacology. Her research output includes peer-reviewed articles addressing regulatory science, pharmaceutical development, healthcare quality, cosmetic regulations, and related multidisciplinary areas. Collectively, these publications have contributed to academic discussions concerning pharmaceutical quality assurance and regulatory compliance.[1]

Research Impact

The measurable research impact of Shalini Singh is reflected through publication productivity, citation performance, and continuing engagement with pharmaceutical and regulatory research communities. Her work contributes to scientific understanding of clinical pharmacology, pharmaceutical quality systems, cosmetic regulation, and healthcare policy. Citation indicators demonstrate that her publications have been referenced by subsequent investigations, supporting ongoing knowledge development within pharmaceutical sciences.[1][2]

Award Suitability

Based on her documented publication record, research activity, citation profile, and professional engagement within clinical pharmacology and pharmaceutical regulation, Shalini Singh demonstrates characteristics commonly associated with recognition under the Women Researcher Award presented at the International Top Pharmaceutical Awards. Her contributions illustrate sustained scholarly participation, interdisciplinary collaboration, and commitment to advancing pharmaceutical sciences through research and regulatory excellence.[1][3]

Conclusion

Shalini Singh has established a professional research profile that combines clinical pharmacology, pharmaceutical regulation, cosmetic compliance, and healthcare quality assurance. Through consistent scholarly publications, interdisciplinary collaboration, and evidence-based regulatory research, she contributes to the advancement of pharmaceutical sciences and responsible healthcare innovation. Her academic achievements, publication metrics, and continuing scientific engagement provide a strong foundation for professional recognition within international pharmaceutical research communities.[1][4]

External Links

References

Google Scholar. (n.d.). Shalini Singh – Google Scholar Profile. https://scholar.google.com/citations?user=N3KRvykAAAAJ
Singh, S., Arya, V., Mishra, R. K., & Rajput, S. K. (2026). Clinical Effectiveness of Naturopathic Therapeutic Approaches in the Management of Polycystic Ovary Syndrome: Real-World Evidence. Current Indian Science. Advance online publication. https://doi.org/10.2174/012210299X481816260630115057
Singh, S., Arya, V., Mishra, R. K., Rajput, S. K., Mishra, S., & Rana, M. (2025). Mechanistic and Phytopharmacological Insights into Ayurvedic Botanicals for the Management of Polycystic Ovarian Syndrome. Journal of Ayurvedic and Herbal Medicine. https://doi.org/10.4103/JAHM.JAHM_55_25
Singh, S., Arya, V., Mishra, R. K., Rajput, S. K., & Dhanasekaran, M. (2024). Nanotechnology in the diagnosis and management of polycystic ovary syndrome: A systematic scoping analysis to improve patient care. Next Research. https://doi.org/10.1016/j.nexres.2024.100004
Balkrishna, A., Rana, M., Mishra, S., Srivastava, D., Bhardwaj, R., Singh, S., Rajput, S. K., Arya, V., & Rigano, D. (2023). Incredible Combination of Lifestyle Modification and Herbal Remedies for Polycystic Ovarian Syndrome Management. Evidence-Based Complementary and Alternative Medicine.
https://doi.org/10.1155/2023/3705508

Naglaa Shehab | Drug Discovery and Development | Editorial Board Member

Published on 21/05/202622/05/2026 by Top Pharmaceutical

Editorial Board Member

Naglaa Shehab — Dubai Medical University

Naglaa Shehab
Affiliation	Dubai Medical University
Country	United Arab Emirates
Scopus ID	26424069600
Documents	446
Citations	494
h-index	13
Subject Area	Drug Discovery and Development
Event	International Top Pharmaceutical Awards
ORCID	0000-0002-7514-4055

Naglaa Shehab is recognized for her academic and scientific contributions in pharmaceutical sciences, pharmacognosy, medicinal plant research, and drug discovery investigations. Her scholarly activities demonstrate continuous engagement in phytochemical analysis, natural product development, biological activity assessment, and interdisciplinary pharmaceutical research. Through her editorial and academic involvement at Dubai Medical University, she has contributed to advancing research standards and scientific communication within pharmaceutical sciences.[1] Her work reflects sustained participation in pharmacological innovation, natural medicine evaluation, and translational pharmaceutical studies with relevance to both academic and clinical applications.[2]

Contents

Abstract
Keywords
Introduction
Research Profile
Research Contributions
Publications
Research Impact
Award Suitability
Conclusion
External Links
References

Abstract

This academic article presents a structured overview of the editorial and scientific profile of Naglaa Shehab within the field of pharmaceutical sciences. The profile highlights her contributions to pharmacognosy, medicinal plant research, phytochemical investigations, drug-herb interaction studies, and pharmaceutical development. Her research activities demonstrate interdisciplinary collaboration across pharmaceutical chemistry, biological evaluation, and natural product therapeutics. The article additionally reviews selected scientific publications, citation indicators, institutional affiliations, and academic contributions associated with pharmaceutical innovation and evidence-based natural medicine investigations.[1]

Keywords

Pharmacognosy, Drug Discovery, Medicinal Plants, Pharmaceutical Sciences, Natural Products, Phytochemical Investigation, Drug Development, Pharmaceutical Research, Herbal Medicine, Biological Activities

Introduction

Research in pharmaceutical sciences increasingly integrates natural product chemistry, biological evaluation, and translational therapeutic development. Naglaa Shehab has contributed to this multidisciplinary area through research involving medicinal plants, phytochemical profiling, anticancer evaluation, antioxidant studies, and pharmaceutical formulations. Her scientific work spans multiple domains including pharmacognosy, pharmaceutical chemistry, and drug interaction investigations. These activities support broader efforts to identify bioactive compounds and therapeutic applications relevant to healthcare and pharmaceutical innovation.[3]

Research Profile

Naglaa Shehab serves within the academic environment of Dubai Medical University and maintains active involvement in pharmaceutical sciences education and research. Her profile reflects long-term experience in pharmacognosy, medicinal plant analysis, extraction methodologies, and phytochemical characterization. Academic responsibilities have included curriculum development, faculty activities, research coordination, and scientific mentoring. Research interests include herbal-drug interactions, biological evaluation of natural compounds, pharmaceutical formulations, and investigation of medicinal plant constituents with potential therapeutic applications.[1]

Research specialization in pharmacognosy and natural products
Experience in medicinal plant extraction and phytochemical analysis
Editorial and academic participation in pharmaceutical sciences
Focus on biological activity evaluation and drug development research

Research Contributions

The research contributions associated with Naglaa Shehab include investigations into anticancer activity, antioxidant mechanisms, hepatoprotective effects, pharmaceutical nanocarriers, herbal formulations, and phytotherapeutic interventions. Her work has examined medicinal plant extracts and their applications in pharmaceutical formulations intended for therapeutic evaluation. Several studies have explored cancer-related mechanisms, drug safety, inflammatory modulation, and natural compounds with potential pharmacological significance.[2][4]

Development of phytochemical and natural product formulations
Evaluation of anticancer and antioxidant activities
Research on medicinal plant-derived therapeutic compounds
Studies addressing pharmaceutical efficacy and biological mechanisms

Publications

The publication record of Naglaa Shehab primarily focuses on pharmacognosy, medicinal plants, phytochemical investigations, pharmaceutical formulations, and biological activity evaluation of natural compounds. Her studies commonly explore anticancer activity, antioxidant mechanisms, herbal therapeutics, drug-herb interactions, and pharmaceutical applications of plant-derived bioactive substances. Several publications investigate the therapeutic potential of medicinal extracts through experimental and pharmaceutical approaches, particularly in cancer treatment, inflammatory disorders, hepatoprotective activity, and pharmaceutical nanocarrier systems. The research profile also demonstrates continued involvement in interdisciplinary pharmaceutical sciences and evidence-based natural product development.[3][4]

Research Impact

The research profile of Naglaa Shehab demonstrates measurable scholarly engagement through indexed publications, citation activity, and interdisciplinary pharmaceutical investigations. Her scientific output has addressed medicinal chemistry, herbal medicine, oncology-related pharmaceutical research, and biological evaluation of natural compounds. The documented h-index and citation metrics indicate ongoing academic visibility within pharmaceutical and pharmacognosy-related research communities.[1][5]

Award Suitability

Naglaa Shehab demonstrates suitability for recognition within pharmaceutical and biomedical academic platforms due to her contributions to drug discovery, pharmacognosy, medicinal plant investigations, and pharmaceutical sciences education. Her participation in scientific publishing, interdisciplinary collaborations, and research development aligns with the objectives of international pharmaceutical recognition initiatives. The combination of research productivity, editorial engagement, and pharmaceutical innovation supports her relevance to academic award and editorial board recognition programs.[5]

Conclusion

The academic profile of Naglaa Shehab reflects continued engagement in pharmaceutical sciences, medicinal plant investigations, and natural product research. Her scholarly contributions encompass pharmaceutical formulations, phytochemical analysis, biological evaluation, and interdisciplinary healthcare applications. Through editorial participation, scientific publications, and pharmaceutical research activities, she contributes to ongoing developments within drug discovery and pharmaceutical innovation.[1][2]

External Links

References

ORCID. (2026). Naglaa Shehab ORCID profile and academic activities. ORCID Registry.https://orcid.org/0000-0002-7514-4055
Elsevier. (n.d.). Scopus author details: Naglaa Shehab, Author ID 26424069600. Scopus.https://www.scopus.com/authid/detail.uri?authorId=26424069600
Khalifa, A., Shehab, N.G., et al. (2026). Development of Phyllanthus emblica Extract-Loaded Niosomes for Cancer Treatment: Formulation and In Vitro Evaluation. Pharmaceuticals.DOI:https://doi.org/10.3390/ph19040582
Bou Malhab, L.J., Shehab, N.G., et al. (2023). Potential Anticancer Properties of Calotropis procera: An Investigation on Breast and Colon Cancer Cells. Heliyon.DOI:https://doi.org/10.1016/j.heliyon.2023.e16706
Anbar, H.S., El Wakil, A., Shehab, N.G., et al. (2024). The wound healing and hypoglycemic activates of date palm (Phoenix dactylifera) leaf extract and saponins in diabetic and normal rats. PLOS ONE.
DOI: https://doi.org/10.1371/journal.pone.0308879

Naglaa Shehab| Drug Discovery and Development | Research Excellence Award

Published on 08/04/202608/04/2026 by Top Pharmaceutical

Prof. Dr. Naglaa Shehab| Drug Discovery and Development | Research Excellence Award

Professor | Dubai Medical University | United Arab Emirates

Prof. Naglaa Gamil Shehab is a Professor of Pharmaceutical Sciences at Dubai Medical University, specializing in pharmacognosy, phytochemistry, medicinal plants, and complementary medicine. She holds advanced degrees in pharmacognosy with a strong foundation in phytochemical research and natural product analysis. Her academic career spans progressive roles from teaching and research to senior professorship and academic leadership, including key responsibilities in curriculum development and coordination of multidisciplinary pharmaceutical courses. Her research focuses on the pharmacognostical and phytochemical investigation of medicinal plants, contributing to the validation of natural therapies and alternative medicine through scientific methodologies. With a notable citation record, consistent publication output, and measurable scholarly impact, she has established herself as a recognized contributor to pharmaceutical sciences. She is actively engaged in academic service through editorial contributions, professional memberships, and mentorship of emerging researchers, reflecting sustained commitment to advancing research quality and innovation in pharmacognosy and related disciplines.

Citation Metrics (Google Scholar)

779

600

400

200

779

Citations

i10-index

h-index

View Scopus Profile

View Google Scholar Profile

Top 5 Featured Publications

Impact of phenolic composition on hepatoprotective and antioxidant effects of four desert medicinal plants

– BMC Complementary Medicine and Therapies

Metabolic and biotransformation effects on dietary glucosinolates, their bioavailability and biological effects

– Biotechnology Advances

Antihyperuricemic and xanthine oxidase inhibitory activities of Tribulus arabicus and ursolic acid

– PLOS ONE

Therapeutic potentials of Crataegus azarolus leaves and its isolated compounds

– BMC Complementary Medicine and Therapies

Phenolic profiling and evaluation of contraceptive effect of Salsola imbricata extract

– Evidence-Based Complementary and Alternative Medicine

Wai Har Ng | Drug Discovery and Development | Best Researcher Award

Published on 25/07/202502/08/2025 by Top Pharmaceutical

Ms. Wai Har Ng | Drug Discovery and Development | Best Researcher Award

Senior Research Associate at National Cancer Centre Singapore | Singapore

Ms. Wai Har Ng is a Senior Research Associate at the National Cancer Centre Singapore with over two decades of experience in cancer biology and translational research. His scientific journey spans genetic engineering, molecular oncology, and personalized therapeutics, with a strong focus on hepatocellular carcinoma, peritoneal carcinomatosis, and colorectal cancer. A dynamic contributor to national research consortiums, Ng WH has authored numerous high-impact publications and excels in molecular, cellular, and in vivo experimental platforms. Known for his collaborative spirit, he plays a pivotal role in mentoring, protocol development, and driving clinical translation in cancer therapy through precision medicine and molecular marker discovery.

Publication Profile

Scopus

Education

Ms. Wai Har Ng obtained a Master of Science in Genetic Engineering from University Putra Malaysia (2005), where his dissertation focused on gene expression profiling of oil palm root systems using EST and microarray technology. He earned his Bachelor of Science in Biotechnology (2000) from the same university, working on Arabidopsis root transformation. His foundational education was completed at Chong Hwa Independent High School, Kuala Lumpur, from 1990–2000, with certifications including STPM, SPM, and SRP. His early academic training at SRJK (C) Tsun Jin laid the groundwork for a career defined by scientific curiosity, discipline, and innovation in molecular biosciences.

Experience

Ms. Wai Har Ng currently serves as a Senior Research Associate at the National Cancer Centre Singapore (2017–present), where he spearheads research on molecular therapeutics and biomarker discovery. He previously worked as a Research Officer and Research Associate at the same institute (2004–2017), contributing to groundbreaking oncology studies. Earlier, he served at the Malaysian Agricultural Research & Development Institute (MARDI) from 2003–2004. His academic skillset spans molecular biology, proteomics, imaging, animal studies, and lab management. Proficient in BSL2 safety, grant collaboration, and multidisciplinary research, he plays a key role in mentoring, lab operations, and translational biomedical research.

Awards

While specific awards were not listed, Ng WH’s achievements are evident through his prolific publication record in high-impact journals, participation in national research consortia like the Singapore Peritoneal Oncology Study (SPOS) and Singapore Gastric Cancer Consortium (SGCC), and recognition as a core contributor to precision oncology research. His co-authorship on influential studies in Scientific Reports, Cell Reports Medicine, and International Journal of Molecular Sciences demonstrates academic recognition and leadership. His technical versatility and mentorship roles further highlight his contribution to national cancer research excellence. If formal awards were earned, these would further bolster his already commendable profile.

Research Focus

Ng WH focuses on translational cancer research with emphasis on hepatocellular carcinoma, colorectal cancer, peritoneal carcinomatosis, and liposarcoma. His work integrates drug synergy, molecular profiling, biomarker discovery, and machine learning to optimize personalized cancer therapies. He is proficient in CRISPR, ddPCR, organoid modeling, xenografts, and immunofluorescence microscopy. A key area includes developing predictive molecular signatures for chemotherapy response and leveraging advanced imaging to study tumor behavior. With over 13 peer-reviewed publications, Ng WH bridges basic science and clinical application, contributing to a future where cancer treatment is personalized, precise, and highly effective.

Publication Top Notes

Title: Vinorelbine Improves the Efficacy of Sorafenib against Hepatocellular Carcinoma: A Promising Therapeutic Approach
Journal: International Journal of Molecular Sciences
Year: 2024
Citations: 5

Title: Everolimus Acts in Synergy with Vinorelbine to Suppress the Growth of Hepatocellular Carcinoma
Journal: International Journal of Molecular Sciences
Year: 2024
Citations: 4

Conclusion

Ms. Wai Har Ng is a highly competent and experienced researcher whose scientific contributions have advanced the field of cancer biology and therapeutics. Her technical mastery, consistent publication output, and collaborative involvement with national research consortia highlight her as a valuable asset to the research community. With increased visibility through leadership roles in publications and funding acquisition, she would stand out even more prominently. She is a strong and deserving candidate for the Best Researcher Award, given her sustained excellence, innovation, and impact in translational cancer research.

Efthalia Moustakli | Pharmacology | Best Researcher Award

Published on 22/07/202522/07/2025 by Top Pharmaceutical

Efthalia Moustakli | Pharmacology | Best Researcher Award

Dr. Efthalia Moustakli at University of Ioannina, School of Health Sciences, Greece.

Dr. Efthalia Moustakli, a PhD-trained biologist, excels in medical genetics, molecular biology, and bioinformatics. Currently a postdoctoral researcher and adjunct professor, she integrates clinical, wet-lab, and computational techniques to drive real-world healthcare innovation. With extensive experience in translational science and academic mentorship, she bridges the gap between research and clinical application. Her dedication to advancing reproductive medicine and aging research is reflected in 30+ high-impact publications. Recognized for academic excellence and research leadership, she exemplifies commitment to impactful science and interdisciplinary collaboration across education, technology, and medicine.

Publication Profile

Google Scholar

Education

Dr. Efthalia Moustakli earned her PhD in Medical Genetics from the University of Ioannina, Greece, with her dissertation graded “Excellent” and focused on telomere and mitochondrial recombination in spermatozoa. She previously completed an Integrated Master’s in Biological Applications and Technology, also from the University of Ioannina, where her thesis on genetic abnormalities. Her academic journey reflects a strong foundation in genetics, genomics, and reproductive biology, complemented by international training in Germany, showcasing her commitment to advancing precision and reproductive medicine through rigorous scientific research and interdisciplinary learning.

Experience

Dr. Efthalia Moustakli is currently a Postdoctoral Researcher at the Department of Informatics and Telecommunications, University of Ioannina, focusing on molecular aging and bioinformatics. She also serves as an Adjunct Professor in the Nursing Department. Previously, she worked as a Junior Embryologist at Genesis Athens, a Molecular Biologist on the EU-funded PathAge project, and as a trainee in Germany at Universitätsklinikum Jena. Her experience spans clinical research, wet-lab diagnostics, data analysis, and teaching, highlighting her ability to navigate both academia and real-world clinical settings with excellence and innovation.

Awards

Dr. Efthalia Moustakli has been recognized for her exceptional contributions to reproductive science and molecular biology, earning top academic grades in both her PhD and Integrated Master’s programs. Her work on oxidative stress, microRNAs, and genetic diagnostics has gained international attention through 30+ peer-reviewed publications. She has actively contributed to EU-funded research projects and presented findings at major conferences. Her unique blend of clinical embryology, teaching, and algorithm development distinguishes her as a well-rounded scientist. A strong candidate for the Best Researcher Award, she exemplifies academic rigor, innovation, and interdisciplinary impact.

Research Focus

Dr. Efthalia Moustakli specializes in reproductive health, infertility, oxidative stress, NGS data meta-analysis, and clinical genetics. Her postdoctoral work delves into the molecular mechanisms of aging, particularly in relation to telomeres and mitochondrial function. Through projects like PathAge, she integrates computational approaches with clinical data to enhance diagnostic and therapeutic insights. Her research interests span microbiome impacts, ART (Assisted Reproductive Technology), and biomarkers for reproductive outcomes, aiming to translate molecular findings into practical healthcare improvements. She combines bioinformatics, wet-lab, and clinical insight to support advances in personalized and preventative medicine.

Publication Top Notes

Qun Tang | Drug Discovery and Development | Best Researcher Award

Published on 02/07/202502/07/2025 by Top Pharmaceutical

Qun Tang | Drug Discovery and Development | Best Researcher Award

Dr. Qun Tang, Nanchang university, China

Dr. Qun Tang earned his Ph.D. in Chemistry from USTC in 2005. Following postdoctoral research in South Korea and Sweden, he launched his independent lab at Nanchang University in 2010. His research focuses on Mn-based contrast agents 🧲, arsenic-derived anticancer drugs 💊, and innovative treatments for liver diseases using low phosphate stress (LPS) approaches 🧬. With 46 SCI papers, 1,489 citations 📚, and 3 authorized patents, Dr. Tang is a key contributor to pharmaceutical sciences. He is a Standing Committee Member of Jiangxi Pharmaceutical Society and collaborates with leading researchers to advance drug development globally.

Publication Profile

Scopus

Education

Dr. Qun Tang earned his Ph.D. in January 2005 from the University of Science and Technology of China (USTC) 🎓. After postdoctoral collaborations in South Korea and Sweden 🌍, he returned to Nanchang University in March 2010 to begin his independent research career 🔬. His work has focused on manganese (Mn)-based materials for medical imaging contrast agents 🧲 and the development of novel arsenic-based anticancer drugs 💊. Currently, Dr. Tang is pioneering research on low phosphate (Pi) stress (LPS)-based strategies for the prevention and treatment of diseases, particularly targeting liver-related conditions 🧬. His contributions continue to shape pharmaceutical innovation globally.

Professional Memberships

Dr. Qun Tang holds a distinguished position as a Standing Committee Member of the Jiangxi Provincial Pharmaceutical Society 🏛️. This prestigious role reflects his commitment to advancing pharmaceutical sciences within the region and contributing to public health initiatives at the provincial level 📈. Through this membership, Dr. Tang actively engages in scientific discourse, policy guidance, and collaborative research opportunities with fellow experts across Jiangxi and beyond 🤝. His leadership within the society underscores his dedication to professional excellence and innovation in drug development and pharmaceutical research 💊🔬. This role further enhances his influence within China’s scientific and medical communities.

Research Focus

Dr. Qun Tang’s research squarely targets phosphate‑modulated liver oncology and theranostics 🧬🩺. He engineers inorganic‑phosphate binders and polymeric drug‑loading beads 🟤 to perform trans‑arterial embolization, simultaneously starving tumors and reshaping the micro‑environment 🎯. By blocking XPR1‑mediated phosphate efflux, his team triggers mitochondrial dysfunction in hepatocellular carcinoma cells ⚡️, while low‑Pi stress irreversibly repolarizes tumor‑associated macrophages 🛡️ and dampens angiogenesis 🌱. Tang also discovers how binders like sevelamer deactivate hepatic stellate cells to reverse fibrosis 🧫. Overall, his work fuses immunometabolism, interventional radiology, and targeted drug delivery to forge next‑gen therapies for liver cancer and chronic liver disease.

Publication Top Notes

Transarterial Embolization Using an Inorganic Phosphate Binder Modulates Immunity- and Angiogenesis-Related Factors in a Rat Model of Liver Cancer

Design and progress of drug-loading polymeric bead for tumor embolization

Inhibition of XPR1-dependent phosphate efflux induces mitochondrial dysfunction: A potential molecular target therapy for hepatocellular carcinoma?

Sevelamer reverses liver fibrosis by deactivation of hepatic stellate cells

Irreversible repolarization of tumour-associated macrophages by low-Pi stress inhibits the progression of hepatocellular carcinoma

Jameel Al-Tamimi | Biopharmaceutics | Best Researcher Award

Published on 25/04/202525/04/2025 by Top Pharmaceutical

Jameel Al-Tamimi | Biopharmaceutics | Best Researcher Award

Dr. Jameel Al-Tamimi, King Saud University, Saudi Arabia

Dr. Jameel Al-Tamimi is a distinguished researcher with a Ph.D. in Immunogenetics from King Saud University, Riyadh, Saudi Arabia. His research focuses on immunology, particularly the role of Killer Immunoglobulin-like Receptors (KIRs) in leukemia. He has expertise in molecular techniques, immunology, and forensic entomology. Dr. Al-Tamimi has published numerous research articles and has contributed to various academic committees. His teaching experience spans courses in molecular biology, human physiology, and medical entomology.

Publication Profile

Google Scholar

Education

Dr. Jameel Al-Tamimi 🎓 is a distinguished researcher with a Ph.D. in Immunogenetics (Excellent 4.9/5) from King Saud University, where his thesis explored the Role of Killer Immunoglobulin-like Receptors (KIRs) with HLA Ligands in Saudi Leukemia Patients 🧬. He also holds an M.Sc. in Entomology and Parasitology (Excellent 4.9/5), investigating the anti-inflammatory effects of Pachycondyla sennaarensis (Samsum Ant) venom in male albino rats 🐜🧪. Dr. Al-Tamimi earned his B.Sc. in Biology (Very Good 89.9/100) from Thamar University, Yemen, with research focused on physiological changes in viral hepatitis (HbsAg and HCV) patients at Thamar Hospital 🧫🦠.

Experience

Dr. Jameel Al-Tamimi 🧑‍🔬 brings a wealth of academic and research experience. Since 2023, he has served on the Scientific Committee for the Researcher Support Program (RSPD) and Research Groups Program (RGP) at the Deanship of Scientific Research 📚. At King Saud University, he contributed to key committees, including labs, academic accreditation, exams, and graduate studies 🏛️. He supervised both the endocrinology and immunology laboratories 🧪 and mentored undergraduate and master’s students 🎓. Skilled in handling rats, mice, and insects 🐭🦗, Dr. Al-Tamimi is also proficient in advanced molecular biology, immunology, and physiology techniques 🧬🔬.

Awards

Dr. Jameel Al-Tamimi 🎓 has been recognized for his academic excellence with several prestigious awards. In 2015, he received an acknowledgment certificate from the Chairman of the Center of Excellence in the Development of Science and Mathematics Education at King Saud University 🏅, highlighting his contribution to scientific advancement. Earlier, in 2013, he was honored with a Certificate of Appreciation (General Prize) during the first Graduate Student Annual Scientific Meeting at KSU 📜🎉. These achievements reflect his dedication to academic excellence, innovation in research, and commitment to the scientific community 🌟📚.

Research Focus

Dr. Jameel Al-Tamimi is a multidisciplinary biomedical researcher whose primary focus lies in oxidative stress, wound healing, diabetes, and nanoparticle therapeutics. His work spans nanomedicine, immunomodulation, and natural product pharmacology, particularly in evaluating the biological activities of camel milk peptides, selenium and zinc oxide nanoparticles, and bioactive plant extracts. Dr. Al-Tamimi’s studies contribute significantly to redox biology, diabetic complications, and biofabrication of therapeutic agents, offering innovative strategies for combating chronic diseases and enhancing healing processes. 🧫💊🐫 His collaborative work reflects a strong emphasis on toxicology, regenerative medicine, and bio-nanotechnology.

Publication Top Notes

Camel milk peptide improves wound healing in diabetic rats by orchestrating the redox status and immune response

Wound healing of different molecular weight of hyaluronan; in-vivo study‏

Folic acid and melatonin mitigate diabetic nephropathy in rats via inhibition of oxidative stress‏

Synthesis, structural characterization of silver (I)-NHC complexes and their antimicrobial, antioxidant and antitumor activities‏

Potential effects of the combination of nicotinamide, vitamin B2 and vitamin C on oxidative-mediated hepatotoxicity induced by thioacetamide‏

Efficacy of a Methanolic Extract of Adansonia digitata Leaf in Alleviating Hyperglycemia, Hyperlipidemia, and Oxidative Stress of Diabetic Rats‏

Antioxidant Bioactivity of Samsum Ant (Pachycondyla sennaarensis) Venom Protects against CCL₄‐Induced Nephrotoxicity in Mice‏

Biofabrication of Zinc Oxide Nanoparticle from Ochradenus baccatus Leaves: Broad‐Spectrum Antibiofilm Activity, Protein Binding Studies, and In Vivo Toxicity …‏

Nibras Mohammed Sahi | Drug Delivery Systems | Women Researcher Award

Published on 08/03/202508/03/2025 by Top Pharmaceutical

Nibras Mohammed Sahi | Drug Delivery Systems | Women Researcher Award

Assist. Prof. Dr. Nibras Mohammed Sahi, Ministry of Higher Education and Scientific Research, University of Babylon, Iraq

Dr. Nebras Mohammed Sahi 🦋, an Assistant Professor at the University of Babylon, specializes in entomology and plant extracts 🌿. Her research explores insect-derived products and medicinal plant applications in anticancer and antibacterial treatments 🧪. She has contributed to high-impact journals 📄 indexed in SCI and Scopus. Dr. Sahi prepared the propolis and Alhagi maurorum extract used in her latest research. Her work advances medicine, agriculture, and sustainability 🌍. With a citation index of 3, she actively collaborates on innovative biological studies. 💡🔬

Publication Profile

orcid

Professional Background

Dr. Nibras Mohammed Sahi 🦋, an Assistant Professor, specializes in entomology and plant extracts, focusing on the study of insects and their beneficial products. Her research explores the diverse applications of insect-derived compounds in medicine 💊, agriculture 🌱, and sustainability 🌍. Through collaborations with universities and research institutions, she investigates innovative ways to harness the potential of insects for ecological and economic benefits. Driven by a passion for scientific discovery 🔬, Dr. Sahi’s work contributes to advancements in bio-based solutions, aiming to enhance environmental conservation and agricultural productivity while promoting sustainable development.

Ongoing Research

Dr. Nibras Mohammed Sahi 🦋 is actively engaged in research on insect-derived products and plant extracts, with a particular focus on propolis 🐝 and Alhagi maurorum 🌿 for cancer 🧬 and antibacterial 🦠 applications. Her studies explore the therapeutic potential of these natural compounds, aiming to develop innovative solutions in medicine 💊 and biotechnology. While her work aligns with prestigious award categories, highlighting specific project funding 💰, collaborations 🤝, or research grants would further strengthen her academic profile. Through her dedication to scientific discovery 🔬, Dr. Sahi contributes to advancements in natural product research and sustainable healthcare solutions.

Professional Memberships

Dr. Nibras Mohammed Sahi 🦋 has not listed any editorial appointments, active collaborations, or professional memberships. However, participation in scientific societies 🏛️, international conferences 🎤, or editorial boards 📑 would significantly enhance her academic profile. Engaging in peer-reviewed journals 📚, contributing to scientific committees 🏅, or collaborating on global research initiatives 🌍 would further establish her influence in the field of entomology and natural product research. Highlighting such professional engagements would strengthen her candidacy, showcasing her dedication to advancing scientific knowledge 🔬 and fostering collaborations that drive innovation in medicine 💊, agriculture 🌱, and sustainability 🌿.

Research Focus

Assist. Prof. Dr. Nibras Mohammed Sahi’s research primarily focuses on microbiology 🦠, antibiotic resistance 💊, and bioactive compounds 🌱. His studies encompass pathogenic bacteria identification 🧫, antimicrobial activity testing 🧪, and molecular genetics 🧬 related to infectious diseases. He has extensively investigated natural plant extracts 🌿 and fungal metabolites 🍄 for their antibacterial and antifungal properties, along with genetic factors in diseases 🧑‍⚕️ like hepatitis B and colorectal cancer. His work also extends to insecticidal bioactive compounds 🪲 and their effects. His research contributes significantly to public health 🏥, pharmacology 💉, and molecular diagnostics 🔬.

Publication Top Notes

Molecular & Antibiotic Sensitivity Pattern Study of Acute Otitis Media, Tonsillitis & Periodontitis among Different Ages of Patients of Al-Hashmia General Hospital, Primary Care Centers & Private Clinic in Babylon Province

Analysis of Methanolic extract of Secondary Metabolites Released by Candida glabratus using GC-MS and Evaluation of Its Antimicrobial Activity

Detection of Bioactive Compounds of Raphanus sativus Using GC-MS and FT-IR Technical Analysis and Determination of its Anti-Bacterial and Anti-Fungal Activity.

Isolation and Identification of Some Pathogenic Bacteria from Otitis Media in Babylon Governorate

Antimicrobial Effect of the Crude Phenolic, Alkaloid and Terpenoid Compounds Extracts of Myrtus Communis L. against Human Gram-Negative Pathogenic Bacteria

Salih PAŞA | Pharmaceutical Chemistry | Best Researcher Award

Published on 28/02/202528/02/2025 by Top Pharmaceutical

Salih PAŞA | Pharmaceutical Chemistry | Best Researcher Award

Assoc. Prof. Dr Salih PAŞA, Afyon Kocatepe University, Turkey

Assoc. Prof. Dr. Salih PAŞA is an esteemed inorganic chemist specializing in pharmaceutical chemistry, anticancer research, and catalytic investigations. He earned his BSc (2007), MSc (2010), and PhD (2014) in Inorganic Chemistry. With extensive expertise in boron compounds, biodegradable polymers, and spectroscopy techniques, he has significantly contributed to Schiff base ligand coordination chemistry and Suzuki coupling reactions. Currently, he serves at Afyon Kocatepe University, Turkey. His pioneering work on boron-based cancer therapeutics and water purification underscores his impactful research.

Publication Profile

google scholar

Education

Assoc. Prof. Dr. Salih Paşa 🎓 has built a strong academic foundation in chemistry, specializing in inorganic chemistry. He earned his Bachelor of Science (BSc) degree in Chemistry (2002-2007) 🧪, followed by a Master of Science (MSc) in Inorganic Chemistry (2007-2010) ⚗️. His passion for research and scientific exploration led him to pursue a PhD in Inorganic Chemistry (2010-2014) 🔬. Through years of dedication, he has contributed significantly to the field, advancing knowledge in chemical sciences. His academic journey reflects a commitment to excellence, making valuable contributions to research and education in inorganic chemistry. 📚✨

Research Interest

Assoc. Prof. Dr. Salih Paşa 🔬 focuses his research on the coordination chemistry of polydentate ligands, particularly thio Schiff bases and their transition metal complexes. His work explores their analytical applications, synthetic utility, and biological activity 🧪. He is especially interested in palladium complexes of (N,O,S) and (N,O,P) type ligands, known for their catalytic role in Suzuki coupling reactions ⚗️. Additionally, he investigates boronic acids, unique boron-based compounds that act as Lewis acids, forming reversible covalent bonds with sugars, amino acids, and other Lewis base donors. His studies contribute significantly to advancing inorganic and organometallic chemistry. 🌟

Instrumental Expertise

Assoc. Prof. Dr. Salih Paşa 🎓 possesses extensive expertise in advanced analytical instrumentation, crucial for modern chemical research. He is highly skilled in techniques such as LC-MS/MS, NMR (¹³C & ¹H), XRD, SEM, FTIR, UV-Vis, AAS, GC, and thermal analysis 🔬⚗️. His proficiency in single-crystal X-ray diffraction studies allows for precise molecular structure determination, enhancing the understanding of complex chemical compounds 🧪. With a strong command of these instrumental techniques, he contributes significantly to inorganic and materials chemistry, facilitating groundbreaking research in coordination chemistry, catalysis, and boron-based compounds. His expertise ensures high precision in chemical analysis.

Future Potential

Assoc. Prof. Dr. Salih Paşa 🌱🔬 is actively exploring innovative research in sustainable chemistry and materials science. His recent work focuses on developing biodegradable polymer materials from waste potato starch, contributing to green chemistry and environmental sustainability 🌍♻️. Additionally, his research on the polymerization of Schiff base ligands opens new possibilities in advanced materials, with potential applications in catalysis, drug delivery, and nanotechnology ⚗️. Through his dedication to eco-friendly solutions and cutting-edge polymer research, he aims to revolutionize materials science, creating sustainable alternatives that benefit both industry and the environment. His work paves the way for a greener future. 🌟

Scientific Recognition

Assoc. Prof. Dr. Salih Paşa 📚🔬 has earned significant scientific recognition through multiple publications in high-impact SCI journals, including Chinese Chemical Letters, Inorganica Chimica Acta, Polyhedron, Applied Catalysis A, Applied Organometallic Chemistry, and Tetrahedron: Asymmetry 🏆. His collaborations with international researchers, particularly from Kazakh-British Technical University, highlight his global academic influence 🌍🤝. His contributions to catalysis, drug discovery, and polymer chemistry reinforce the importance of his research, driving advancements in these fields. Through his dedication and impactful studies, he continues to shape the future of inorganic and organometallic chemistry. ⚗️✨

Research Focus

Assoc. Prof. Dr. Salih Paşa’s research primarily focuses on green chemistry 🌱, nanotechnology 🧪, and materials science 🏗️. His work includes the green synthesis of nanoparticles ⚛️, biodegradable materials for eco-friendly applications 🌍, and catalysis in organic synthesis 🔬. He has contributed significantly to biodegradable food packaging 🍽️, anticancer drug discovery 🏥, and advanced polymer materials 🏭. His studies on Schiff bases 🧬, metal complexes ⚗️, and biocompatible materials 🔄 highlight his expertise in designing sustainable and functional materials with industrial and biomedical applications. His work aligns with pharmaceutical chemistry 💊, material engineering 🏢, and green nanotechnology 🌿.

Publication Top Notes

Green synthesis of silver nanoparticles via Cynara scolymus leaf extracts: The characterization, anticancer potential with photodynamic therapy in MCF7 cells

The fabrication of bilayer polylactic acid films from cross-linked starch as eco-friendly biodegradable materials: synthesis, characterization, mechanical and physical properties

Silane doped biodegradable starch-PLA bilayer films for food packaging applications: Mechanical, thermal, barrier and biodegradability properties

Synthesis, characterization and catalytic behavior in the Suzuki reaction of Schiff base and its complexes and the optical properties of nickel complex used in the fabrication …

Flavonoids from Sideritis Species: Human Monoamine Oxidase (hMAO) Inhibitory Activities, Molecular Docking Studies and Crystal Structure of Xanthomicrol

Synthesis, characterization, electrochemical behaviors and applications in the Suzuki–Miyaura cross-coupling reactions of N2S2O2 thio Schiff base ligand and its Cu (II), Co …

Physicochemical properties for food packaging and toxicity behaviors against healthy cells of environmentally friendly biocompatible starch/citric acid/polyvinyl alcohol …

The synthesis of boronic-imine structured compounds and identification of their anticancer, antimicrobial and antioxidant activities

Structural investigation of raw clinoptilolite over the Pb2+ adsorption process from phosphoric acid

Tamara Shushpanova | Drug Discovery and Development | Best Researcher Award

Published on 25/02/202525/02/2025 by Top Pharmaceutical

Tamara Shushpanova | Drug Discovery and Development | Best Researcher Award

Prof Tamara Shushpanova,Tomsk National Research Medical Center of Russian Academy of Science, Russia

🧠 Tamara Vladimirovna Shushpanova – a leading researcher at the Tomsk National Research Medical Center of the Russian Academy of Sciences, specializes in neurochemistry and neuropharmacology 🧪. Her research focuses on the benzodiazepine receptor system in addiction, studying ligand binding in alcohol dependence using molecular docking with GABAA receptor sites. She has authored 100+ scientific papers, holds 5 patents, and has contributed to major conferences (EPA, WPA, ECNP) 📚. With extensive work on innovative molecules Halodif and Halonal, her contributions drive advancements in psychiatry, pharmacology, and addiction medicine. 🎓🔬

Publication Profile

orcid

Education

Prof. Tamara Shushpanova is a dedicated researcher at the Laboratory of Neurobiology, Russian Academy of Sciences 🧠. Her work spans Neurochemistry, Clinical Pharmacology, Psychiatry, and Addiction Medicine 🏥. She has contributed significantly to understanding ethanol’s effects on the human brain and targeted therapies for correction. Notable publications include Molecular-Cellular Targets of the Pathogenetic Action of Ethanol in the Human Brain in Ontogenesis, Halonal: An Original Benzoylated Phenobarbital Derivative Anticonvulsant, and A Novel Urea Derivative Anticonvulsant 📖. Through her research, she advances treatments for neurological disorders, enhancing clinical applications and therapeutic strategies 🔬.

Professional Memberships

Prof. Tamara Shushpanova is an active member of several prestigious professional organizations in neuroscience and psychiatry 🌍. She is affiliated with the European Psychiatric Association (EPA), the World Psychiatric Association (WPA), and the European College of Neuropsychopharmacology (ECNP) 🏥. These memberships connect her with leading experts, enabling collaboration on cutting-edge research in neurochemistry, clinical pharmacology, and addiction medicine 🔬. Through these associations, she contributes to global discussions on mental health, pharmacological advancements, and innovative therapeutic strategies 🧠. Her involvement ensures she remains at the forefront of scientific progress, shaping the future of psychiatry and neurobiology 📚.

Academic Research

Prof. Tamara Shushpanova actively shares her research on ResearchGate 📚, where her contributions to neurochemistry, clinical pharmacology, and psychiatry are accessible to the global scientific community 🌍. Her profile serves as a platform for collaboration, knowledge exchange, and engagement with fellow researchers 🔬. Additionally, she provides links to relevant identification and certification documents, ensuring transparency and credibility in her academic and professional endeavors 🏅. By maintaining an active digital presence, she enhances the visibility of her work, fostering innovation and scientific progress in the field of neuroscience and pharmacology 🧠

Research Focus

Tamara Shushpanova is a distinguished researcher specializing in neuropharmacology 🧠💊, medicinal chemistry ⚗️, and molecular neuroscience 🔬. Her work primarily focuses on the development of novel anticonvulsants, particularly targeting GABAA receptors for conditions like epilepsy and alcohol withdrawal syndrome. She explores drug delivery systems 🚀, enantiomeric drug behavior 🔄, and neuroimmune interactions 🧬. Her research spans molecular docking, chemometric analysis, and in vivo pharmacological studies, contributing to innovative treatments for neurological disorders. Additionally, she investigates prenatal alcohol exposure 🍷🚼 and its impact on brain development, emphasizing glioblasts and neuronal receptor formation in neuroimmune regulation.